Lv4
692 积分 2021-09-22 加入
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia
2天前
已完结
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin
2天前
已完结
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
2天前
已完结
Nonsense-mediated RNA decay: an emerging modulator of malignancy
5天前
已完结
ADAM9 mediates the interleukin-6-induced Epithelial–Mesenchymal transition and metastasis through ROS production in hepatoma cells
10天前
已完结
Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9
10天前
已完结
CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation
15天前
已完结
CTP synthase: the hissing of the cellular serpent
16天前
已完结
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
19天前
已完结
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
25天前
已完结
Daptomycin
4年前
已采纳
利用CT图像勾画前列腺癌尖部的研究
4年前
已采纳
成人口服营养补充专家共识
4年前
已采纳
Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
4年前
已采纳
Primary treatment and Recent survival trends in patients with Primary Diffuse Large B-Cell Lymphoma of Central Nervous System,1995-2016: a population-based SEER analysis
4年前
已采纳
Primary treatment and Recent survival trends in patients with Primary Diffuse Large B-Cell Lymphoma of Central Nervous System,1995-2016: a population-based SEER analysis
4年前
已驳回
《临床超声医学杂志》
4年前
已采纳
皖公网安备34019202002308
